Joseph Todisco
At a glance: Joseph Todisco is CEO at CorMedix (CRMD). Their latest SEC Form 4, filed Nov 16, 2026, reported a purchase of $391K. On file: 1 purchase line ($391K) and 1 sale line ($360K).
Disclosed holdings: about $4.3M of CRMD stock: 854,749 shares reported on their latest Form 4 (filed Nov 16, 2026), valued at the Nov 19, 2026 close of $5.04. This counts only CRMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO at CorMedix Inc. (CRMD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Joseph Todisco's InsiderPrint
9 trades from SEC Form 4 filings, 2020 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about once a year, typically $51K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (8)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Stan W. ConnallyCOO · SO · 93% match
- James OfferdahlDirector · LAW · 93% matchTheir buys since 2023: 3 of 3 beat the S&P 500
- Kerrii B. AndersonDirector · LH · 93% match
- Douglas Michael GarisCFO · CTEV · 92% matchTheir buys since 2025: 3 of 3 beat the S&P 500
- Alan W. DuntonDirector · CRMD · 92% matchTheir buys since 2020: 2 of 3 beat the S&P 500
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Every purchase since 2020
From the SEC's insider data sets: each open-market buy by Joseph Todisco, matched to how the stock did over the next 90 days against the S&P 500.
5 of 7 buys beat the S&P 500 (71%), median +8.8% vs. the index. All insider buys: 46%.
| Stock | Filed | 90 days vs. S&P 500 |
|---|---|---|
| CRMD | Mar 14, 2024 | +13.9% |
| CRMD | Sep 8, 2023 | -6.7% |
| CRMD | May 19, 2023 | -24.2% |
| CRMD | Nov 16, 2022 | +12.2% |
| CRMD | Aug 25, 2022 | +8.1% |
| CRMD | May 18, 2022 | +8.8% |
| AMRX | Mar 11, 2020 | +50.4% |
Buys made close together in one stock count once. Price-only returns; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Nov 16SEC | CRMDCorMedix Inc.First buy in 2 yrsPast buys 5/7 beat S&P | Buy | 80,000854,749 held (+10%) | $4.89 | $391K | +3.0% |
| Dec 19SEC | CRMDCorMedix Inc. | Sell Plan | 30,000509,496 held (−6%) | $12.00 | $360K | -58.0% |
- Buy
CEO Joseph Todisco bought $391K of CRMD at $4.89 — first open-market purchase in our records.
- Sell
CEO Joseph Todisco sold $360K of CRMD at $12.00 — pre-scheduled 10b5-1 plan sale.
Follow Joseph Todisco
Get one email when Joseph Todisco files a new purchase or sale. Free.
At most one email a day about Joseph Todisco, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.